Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.03B |
| 2 |
Qualcomm
QCOM
|
+$924M |
| 3 |
Walmart Inc
WMT
|
+$794M |
| 4 |
Marvell Technology
MRVL
|
+$738M |
| 5 |
Amazon
AMZN
|
+$608M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.19B |
| 2 |
GE Aerospace
GE
|
+$1.14B |
| 3 |
Advanced Micro Devices
AMD
|
+$931M |
| 4 |
Intel
INTC
|
+$877M |
| 5 |
NVIDIA
NVDA
|
+$873M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.01% |
| 2 | Consumer Discretionary | 10.18% |
| 3 | Financials | 9.7% |
| 4 | Healthcare | 9.28% |
| 5 | Communication Services | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRNX
1726
DELISTED
Crinetics Pharmaceuticals
CRNX
| $351K | ﹤0.01% |
9,393
-3,641
| -28% | -$135K |
|
1727
Buckle
BKE
$2.16B
| $351K | ﹤0.01% |
8,315
+70
| +0.8% | +$3.46K |
|
1728
Sarepta Therapeutics
SRPT
$2.21B
| $350K | ﹤0.01% |
+19,456
| New | +$368K |
|
1729
Upstart Holdings
UPST
$2.63B
| $348K | ﹤0.01% |
+9,831
| New | +$303K |
|
1730
Celldex Therapeutics
CLDX
$3.07B
| $348K | ﹤0.01% |
9,351
| – | – |
|
1731
AeroVironment
AVAV
$7.56B
| $347K | ﹤0.01% |
2,104
-1,534
| -42% | -$275K |
|
1732
G-III Apparel Group
GIII
$1.17B
| $344K | ﹤0.01% |
+10,193
| New | +$322K |
|
1733
Kymera Therapeutics
KYMR
$9.68B
| $343K | ﹤0.01% |
2,988
| – | – |
|
1734
Horace Mann Educators
HMN
$2.04B
| $342K | ﹤0.01% |
6,616
-1,448
| -18% | -$67.2K |
|
1735
NBT Bancorp
NBTB
$2.67B
| $342K | ﹤0.01% |
6,920
-1,577
| -19% | -$72.1K |
|
1736
Mobileye
MBLY
$7.24B
| $341K | ﹤0.01% |
35,225
| – | – |
|
1737
Transocean
RIG
$6.43B
| $341K | ﹤0.01% |
69,645
-70,714
| -50% | -$442K |
|
1738
Travere Therapeutics
TVTX
$6.23B
| $340K | ﹤0.01% |
+5,987
| New | +$265K |
|
1739
FTI Consulting
FCN
$4.17B
| $339K | ﹤0.01% |
2,277
-931
| -29% | -$152K |
|
1740
CareDx
CDNA
$2.6B
| $339K | ﹤0.01% |
11,891
| – | – |
|
1741
Hilltop Holdings
HTH
$2.21B
| $338K | ﹤0.01% |
8,718
+744
| +9% | +$27.9K |
|
1742
Envista
NVST
$4.31B
| $338K | ﹤0.01% |
12,812
-171,763
| -93% | -$4.33M |
|
1743
FirstCash
FCFS
$9.78B
| $337K | ﹤0.01% |
1,557
-792
| -34% | -$172K |
|
1744
First Trust Global Wind Energy ETF
FAN
$248M
| $336K | ﹤0.01% |
13,454
-10,450
| -44% | -$269K |
|
1745
S&T Bancorp
STBA
$1.76B
| $335K | ﹤0.01% |
6,822
+273
| +4% | +$12.3K |
|
1746
Wendy's
WEN
$1.45B
| $334K | ﹤0.01% |
40,301
+15,948
| +65% | +$114K |
|
1747
Forum Energy Technologies
FET
$916M
| $332K | ﹤0.01% |
+6,615
| New | +$369K |
|
1748
Integra LifeSciences
IART
$1.26B
| $332K | ﹤0.01% |
18,470
-960
| -5% | -$13.4K |
|
1749
Relay Therapeutics
RLAY
$4.19B
| $332K | ﹤0.01% |
17,726
-3,655
| -17% | -$53.1K |
|
1750
Ollie's Bargain Outlet
OLLI
$4.57B
| $330K | ﹤0.01% |
4,295
-34,663
| -89% | -$2.89M |
|
Similar funds
Amundi's Q2 2026 Portfolio in Review
As of Q2 2026, Amundi held 2,193 positions worth $416B, up 13% from $367B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Amundi's Q2 2026 filing shows 151 new, 827 increased, 930 reduced and 130 closed positions. Its largest new stake was FedEx Freight: 684,463 shares worth $103M. The largest sale was Micron Technology, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Financials.
- Amundi's largest Q2 2026 buy was FedEx Freight: 684,463 shares worth $103M.
- Amundi added most to Microsoft in Q2 2026, an estimated $2.03B increase.
- Amundi's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.19B.
- Amundi fully exited Hologic in Q2 2026, selling an estimated $111M.
- Amundi's ten largest holdings make up 34% of its $416B portfolio in Q2 2026.
- Amundi opened 151 new positions and closed 130 in Q2 2026.
- Amundi's portfolio value rose 13% quarter-over-quarter to $416B.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.